non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) histopathology confirmed NSCLC, (2) complete clinical history, immunohistochemical (IHC) results, and PET/CT images were available, (3) no antitumor therapy prior to histopathological analysis and imaging, and (4) no previous history of malignant tumor other than lung cancer.
Exclusion criteria
Exclusion criteria: (1) pathologic subtypes of NSCLC other than squamous (SCC) and adenocarcinomas (ADC), (2) obvious asymmetry in the shape of the psoas major muscle due to trauma, disease, heredity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PET/CT;total glycolysis;Accuracy ;Specificity ;Sensitivity ;Negative predictive value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive predicative value; | — |
Countries
China
Contacts
the First Affiliated Hospital of Soochow University